New SEC Form D filing

Altay Therapeutics, Inc., 2026-10-02

A new SEC Form D private-offering notice from San Carlos, CA, a $45,067,885 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Altay Therapeutics, Inc. site↗ Verified via SEC Form D

Biotech developing oral small molecule inhibitors of transcription factors, including a lead DUX4 inhibitor for facioscapulohumeral muscular dystrophy and a STAT3 inhibitor program for cancer and inflammatory disease

New filing todayFiled to raise $45,067,885First money in 2026-09-17Raised so far $15,738,155HQ (as filed) San Carlos, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified altaytherapeutics.com↗Named in the filing 7 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source